Our results enlarged the mutational spectra of TYR and OCA2, and the identification of novel pathogenic or likely pathogenic variants of OCA will benefit gene diagnostics and genetic counseling for OCA patients. The gene discussed is OCA2; the disease is oculocutaneous albinism.